Xlife Sciences AG
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG00QG3ZN09
XLS
Xlife Sciences AG
GICS: -
·
Sector: -
·
Sub-Sector: -
NAME
Xlife Sciences AG
ISIN
CH0461929603
TICKER
XLS
MIC
XSWX
REUTERS
XLS.S
BLOOMBERG
XLS SW
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Mon, 30.09.2024
Zurich, 30th of September 2024: The management of Xlife Sciences AG (SIX:XLS) was commissioned on September 3, 2024, after an intensive review of all available options and offers from the Board of Directors, to implement a strategy to increase market capitalization and, consequently, the stock price, as well as the liquidity and tradability of the ...
Thu, 19.09.2024
Zurich, 19th of September 2024: Xlife Sciences AG (SIX: XLS) today published its 2024 Half-Year Report and announced significant progress in its business development. Despite a challenging market environment, the company was able to further expand its innovative strength and advance new partnerships and developments within its diversified portfolio...
Thu, 19.09.2024
Zurich, 19th of September 2024: Xlife Sciences AG (SIX: XLS) today published its 2024 Half-Year Report and announced significant progress in its business development. Despite a challenging market environment, the company was able to further expand its innovative strength and advance new partnerships and developments within its diversified portfolio...
Tue, 03.09.2024
Zurich, 3rd of September 2024: Xlife Sciences AG (SIX: XLS) today announced that the Board of Directors has completed the strategic review and, as of September 2, 2024, has tasked management with implementing the process. The shareholders will be informed of the next steps by September 30, 2024, at the latest.
The size and diversity of the portfoli...
Fri, 28.06.2024
Xlife Sciences AG
/ Key word(s): AGMEGM
Xlife Sciences AG: Successful General Assembly and New Trading Hours on the Sparks Segment of SIX
28.06.2024 / 18:00 CET/CEST
Zurich, 28th of June 2024: Xlife Sciences AG (SIX: XLS), a leading company in the development and commercialization of technologies and therapies in the li...
Fri, 28.06.2024
Xlife Sciences AG
/ Key word(s): AGMEGM
Xlife Sciences AG: Successful General Assembly and New Trading Hours on the Sparks Segment of SIX
28.06.2024 / 18:00 CET/CEST
Zurich, 28th of June 2024: Xlife Sciences AG (SIX: XLS), a leading company in the development and commercialization of technologies and therapies in the li...
Wed, 26.06.2024
Xlife Sciences AG
/ Key word(s): Market launch/Product Launch
Xlife Sciences AG Reports Success in Liver Diagnostics – x-nuclear diagnostics GmbH Achieves Market Readiness
26.06.2024 / 07:00 CET/CEST
Zurich, 26th of June 2024: Xlife Sciences AG announces significant progress in the development and application of innovat...
Wed, 26.06.2024
Xlife Sciences AG
/ Key word(s): Market launch/Product Launch
Xlife Sciences AG Reports Success in Liver Diagnostics – x-nuclear diagnostics GmbH Achieves Market Readiness
26.06.2024 / 07:00 CET/CEST
Zurich, 26th of June 2024: Xlife Sciences AG announces significant progress in the development and application of innovat...
Mon, 27.05.2024
Xlife Sciences AG
/ Key word(s): Alliance/Merger
Xlife Sciences AG Announces Strategic Merger Between palleos healthcare GmbH and OCT Clinical GmbH
27.05.2024 / 07:00 CET/CEST
Zurich, 27th of May 2024: Xlife Sciences AG announces the merger of its portfolio company, palleos healthcare GmbH, with OCT Clinical GmbH. This ...
Tue, 30.04.2024
Zurich, 30st of April 2024: Xlife Sciences AG (SIX: XLS) released the 2023 Valuation Report today, which assesses the company's portfolio as of the end of 2023. The evaluation was conducted by the independent consulting firm CYLAD Experts and covers 18 of the total 25 project companies of Xlife Sciences1. The assessment is primarily based on the ri...
Information on product placements
